Catalyst Wire Dossier Catalyst Wire Dossier

OTEZLA

apremilast · Amgen, Inc
Drug timelines are a Plus or Pro feature.

40 regulatory and trial events tracked for OTEZLA, covering 2014-03-21 to 2026-03-04. Get the full timeline:

Most recent: EMA Authorised: Otezla (apremilast) — Amgen Europe B.V.

See pricing